Scientist - Biochemistry, Assay development (9 months, with possible extension)

The company

HexagonFab is a recent spin-off company from the University of Cambridge. Our mission is the development of next-generation sensors for rapid point of care testing. The core of our technology is a novel nanomaterial-based platform that allows near real-time detection of antibody/antigen binding.



The role

Based in our labs in Cambridge, UK, you will be involved in the development of a novel nanomaterial-based immunoassay for the detection of proteins and small molecules.



Your responsibilities

  • Development of immunoassays for protein detection
  • Optimization of the surface chemistry including processes for immobilization of antibodies and improvement of surface passivation protocols
  • Performing experiments to investigate processes for the immobilization of antibodies using linker molecules and methods for reducing non-specific binding
  • The experimental work will be carried out at our laboratories in Cambridge, UK
  • On a day to day basis, you will work closely with researchers in an interdisciplinary team including engineers, chemists and clinicians


Minimum requirements

  • MSc in Chemistry, Biochemistry or related field
  • Good communication and interpersonal skills
  • Self-motivated with initiative and drive


Preferred experience

  • 2+ years experience with development and verification of immunoassays such as ELISA
  • Previous experience with chemFETs or graphene-FETs


What we offer

  • Young, dynamic and fast-paced work environment
  • Be part of the next-era of detection technologies for clinical diagnostics, quality control, and protein engineering
  • Competitive salary
  • Most important off all, join a great team!


Start date: 1. April or by arrangement
Primary location: Cambridge, UK



Application process

1. Send CV with a short e-mail outlining your motivation to info@hexagonfab.com
2. Successful applications will be invited to first stage interview via phone call or video
3. Second round face-to-face interview with members of the team